Glucosamine-Silver Nanoparticle Production Service

Overview of Glucosamine-Silver Nanoparticles

Glucosamine-silver nanoparticles (GlcN-AgNPs) are a type of glyconanoparticle where silver nanoparticles are functionalized with glucosamine molecules. This functionalization enhances the biocompatibility, stability, and biological activity of the nanoparticles, particularly for antimicrobial applications. The conjugation occurs through the formation of a secondary amide linkage between glucosamine and the silver surface, enabling these nanoparticles to show increased antibacterial properties against various bacterial strains.

CD BioGlyco offers a GlcN-AgNPs production service based on our advanced synthesis techniques to deliver high-quality, functionalized nanoparticles tailored for diverse applications. We provide scalable production options, enabling researchers and industries to use GlcN-AgNPs in biomedical research, drug delivery, antimicrobial coatings, and biosensors. Let us help you unlock the full potential of GlcN-AgNPs for your innovative projects.

CD BioGlyco's GlcN-AgNPs production service is powered by our proprietary GlycoNano™ Platform, which forms the foundation of our Glyconanoparticle Development Service. Through this platform, we utilize Advanced Techniques for Glyconanoparticle Development, including chemical reduction, green synthesis, and sonication, to ensure precise and scalable production.

Techniques and methods used in glucosamine-silver nanoparticle production. (CD BioGlyco)

The production process of GlcN-AgNPs involves the precise synthesis and functionalization of silver nanoparticles with glucosamine molecules.

Stage 1: Synthesis of Silver Nanoparticles

Silver nanoparticles are prepared using an ultrasonic-assisted reduction of silver nitrate (AgN O₃) with sodium borohydride (NaBH₄) as the reducing agent. This step ensures well-dispersed nanoparticles.

Stage 2: Functionalization with Glucosamine

The silver nanoparticles are modified with mercaptoundecanoic acid (MUA) to create NHS-terminated AgNPs through an EDC/NHS coupling reaction. Glucosamine is then added to the NHS-activated nanoparticles, allowing the amino group of glucosamine to form a secondary amide linkage with the silver surface.

This process integrates chemical reduction for nanoparticle formation and EDC/NHS coupling chemistry to achieve stable, biocompatible glucosamine conjugation. These methods ensure the production of high-quality nanoparticles with enhanced antimicrobial properties and stability for various applications.

Analytical Techniques for Characterizing Glucosamine-Silver Nanoparticles

These techniques ensure a comprehensive understanding of the physical, chemical, and biological properties of GlcN-AgNPs, making them suitable for biomedical research and industrial applications.

UV-visible spectroscopy

Measures surface plasmon resonance to confirm nanoparticle synthesis and glucosamine functionalization.

FT-Raman spectroscopy

Identifies functional groups and structural changes during functionalization.

1H-NMR spectroscopy

Confirms the formation of secondary amide linkages between glucosamine and silver nanoparticles.

Transmission electron microscopy (TEM)

Observes the size, morphology, and dispersion of nanoparticles.

Field emission scanning electron microscopy (FE-SEM)

Analyzes surface topography and particle size distribution.

Antimicrobial assays

Determines the minimum inhibitory concentrations (MICs) for different bacterial strains.

Analytical techniques for characterizing glucosamine-silver nanoparticles. (CD BioGlyco)

Applications

GlcN-AgNPs demonstrate enhanced antibacterial activity against both gram-positive and gram-negative bacteria, with minimum inhibitory concentrations lower than non-functionalized AgNPs.
GlcN-AgNPs can be potentially used in antimicrobial coatings, drug delivery systems, and wound healing due to their biocompatibility and stability.
GlcN-AgNPs can serve as model systems for studying carbohydrate-protein and carbohydrate-cell interactions and for developing biosensors.

Advantages

The glucosamine coating allows better interaction with bacterial cell walls, improving the efficacy of the nanoparticles.
Functionalization reduces cytotoxicity while maintaining strong biological activity.
The glycosylation process improves dispersion and colloidal stability over a wide range of pH values.

Frequently Asked Questions

What custom options are available for GlcN-AgNPs?
Our service offers customizable options, including particle size, silver concentration, and glucosamine surface density. These features can be tailored to meet specific research and industrial needs.
How does CD BioGlyco ensure the stability and quality of GlcN-AgNPs?
Based on our GlycoNano™ Platform, we employ advanced techniques like chemical reduction, EDC/NHS coupling, and sonication to ensure the nanoparticles are highly stable and consistent. Comprehensive quality control processes validate their performance across various applications.

At CD BioGlyco, our GlcN-AgNPs production service provides dependable and custom solutions for the production of high-quality GlcN-AgNPs. Contact Us today to discover how our products can support and enhance your research.

This service is for Research Use Only, not intended for any clinical use.